Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP.
Kobayashi Y, Hatta Y, Hojo A, Kura Y, Uchino Y, Takahashi H, Kiso S, Hirabayashi Y, Yagi M, Kodaira H, Kurita D, Tanaka T, Miura K, Iriyama N, Kobayashi S, Sawada U, Sugitani M, Takeuchi J. Kobayashi Y, et al. Among authors: hojo a. Exp Ther Med. 2012 Feb;3(2):304-308. doi: 10.3892/etm.2011.387. Epub 2011 Nov 22. Exp Ther Med. 2012. PMID: 22969886 Free PMC article.
An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma.
Miura K, Takei K, Kobayashi S, Kiso S, Hirabayashi Y, Hojo A, Kodaira H, Yagi M, Kurita D, Kobayashi Y, Tanaka T, Iriyama N, Hatta Y, Kura Y, Yamazaki T, Sawada U, Takeuchi J. Miura K, et al. Among authors: hojo a. Int J Hematol. 2011 Jul;94(1):90-96. doi: 10.1007/s12185-011-0884-x. Epub 2011 Jun 23. Int J Hematol. 2011. PMID: 21695600
Attenuated immunochemotherapy for diffuse large B-cell lymphoma.
Miura K, Kobayashi Y, Hojo A, Hatta Y, Takeuchi J. Miura K, et al. Among authors: hojo a. Lancet Oncol. 2011 Aug;12(8):725; author reply 725-6. doi: 10.1016/S1470-2045(11)70152-8. Lancet Oncol. 2011. PMID: 21807340 No abstract available.
A case series of Bacillus cereus septicemia in patients with hematological disease.
Uchino Y, Iriyama N, Matsumoto K, Hirabayashi Y, Miura K, Kurita D, Kobayashi Y, Yagi M, Kodaira H, Hojo A, Kobayashi S, Hatta Y, Takeuchi J. Uchino Y, et al. Among authors: hojo a. Intern Med. 2012;51(19):2733-8. doi: 10.2169/internalmedicine.51.7258. Epub 2012 Oct 1. Intern Med. 2012. PMID: 23037464 Free article.
Efficacy of a dose-intensified CHOP (Double-CHOP) regimen for peripheral T-cell lymphomas.
Iriyama N, Takahashi H, Hatta Y, Miura K, Kobayashi Y, Kurita D, Hirabayashi Y, Hojo A, Kodaira H, Yagi M, Kiso S, Uchino Y, Nakagawa M, Kusuda M, Kobayashi S, Horikoshi A, Kura Y, Yamazaki T, Sawada U, Takeuchi J. Iriyama N, et al. Among authors: hojo a. Oncol Rep. 2013 Feb;29(2):805-11. doi: 10.3892/or.2012.2143. Epub 2012 Nov 15. Oncol Rep. 2013. PMID: 23166041
Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.
Kobayashi Y, Hatta Y, Sugitani M, Hojo A, Nakagawa M, Kusuda M, Uchino Y, Takahashi H, Kiso S, Hirabayashi Y, Yagi M, Kodaira H, Kurita D, Miura K, Iriyama N, Kobayashi S, Kura Y, Horikoshi A, Sawada U, Takeuchi J, Takei M. Kobayashi Y, et al. Among authors: hojo a. Leuk Lymphoma. 2014 Nov;55(11):2514-9. doi: 10.3109/10428194.2014.889827. Epub 2014 Mar 17. Leuk Lymphoma. 2014. PMID: 24491027
Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
Kurita D, Miura K, Nakagawa M, Ohtake S, Sakagami M, Uchino Y, Takahashi H, Kiso S, Hojo A, Kodaira H, Yagi M, Hirabayashi Y, Kobayashi Y, Iriyama N, Kobayashi S, Hatta Y, Kura Y, Sugitani M, Takei M. Kurita D, et al. Among authors: hojo a. Int J Hematol. 2015 Jun;101(6):585-93. doi: 10.1007/s12185-015-1780-6. Epub 2015 Mar 17. Int J Hematol. 2015. PMID: 25776837
Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy.
Miura K, Takahashi H, Nakagawa M, Izu A, Sugitani M, Kurita D, Sakagami M, Ohtake S, Uchino Y, Hojo A, Kodaira H, Yagi M, Kobayashi Y, Iriyama N, Kobayashi S, Kiso S, Hirabayashi Y, Hatta Y, Takei M. Miura K, et al. Among authors: hojo a. Leuk Lymphoma. 2016;57(6):1335-41. doi: 10.3109/10428194.2015.1096352. Epub 2015 Oct 22. Leuk Lymphoma. 2016. PMID: 26390147
47 results